[Liver disease patients with anti-HCV. What can be done?]

[Immunoproliferative small intestinal disease (IPSID): IPSID-like lymphomas, IPSID equivalents?, in 12 Spanish patients].

Sangre·1995

[Post-therapeutic evolution and prognostic factors of intestinal lymphomas, Retrospective analysis of 42 cases].

Sangre·1993

[Cancer of the middle third of the choledochus: an infrequent diagnosis].

Revista espanola de enfermedades digestivas·1993

[Eosinophilia and ascites as an expression of a subserous form of eosinophilic gastroenteritis].

Revista clinica espanola·1992

[Jaundices in pregnancy].

Revista espanola de enfermedades digestivas·1991

[Immunological and biochemical factors associated with spontaneous bacterial peritonitis].

Revista espanola de enfermedades digestivas·1991

[Neoplastic angiogenesis].

Anales de medicina interna (Madrid, Spain : 1984)·2009

[Immune response in optic neuromyelitis].

Anales de medicina interna (Madrid, Spain : 1984)·2009

[Autoimmune pancreatitis. Related to a case].

Anales de medicina interna (Madrid, Spain : 1984)·2009

[Severe ocular symptoms as an initial manifestation of superior vena cava syndrome].

Anales de medicina interna (Madrid, Spain : 1984)·2009

[Diagnosis of the spontaneous subarachnoid hemorrhage with short bleeding or long evolution: report of one case].

Anales de medicina interna (Madrid, Spain : 1984)·2009

[Gastroesophageal reflux as a cause of vocal dysfunction].

Anales de medicina interna (Madrid, Spain : 1984)·2009

Light Source-Dependent Photooxidation of Therapeutic Monoclonal Antibodies: A Comparative Study of Light-Emitting Diode (LED) and Fluorescent Exposure.

Pharmaceutical development and technology·2026

Single-cell immune profiling of blood and thrombus in cancer-associated thrombosis.

iScience·2026

BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.

Cureus·2026

Myeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.

Open life sciences·2026

Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

EClinicalMedicine·2026

Non-coding RNAs as predictive factors of oncological outcomes in plasma cell myeloma.

Oncology reviews·2026

Related Experiment Videos

[Liver disease patients with anti-HCV. What can be done?]

Related Concept Videos

[Immunoproliferative small intestinal disease (IPSID): IPSID-like lymphomas, IPSID equivalents?, in 12 Spanish patients].

[Post-therapeutic evolution and prognostic factors of intestinal lymphomas, Retrospective analysis of 42 cases].

[Cancer of the middle third of the choledochus: an infrequent diagnosis].

[Eosinophilia and ascites as an expression of a subserous form of eosinophilic gastroenteritis].

[Jaundices in pregnancy].

[Immunological and biochemical factors associated with spontaneous bacterial peritonitis].

[Neoplastic angiogenesis].

[Immune response in optic neuromyelitis].

[Autoimmune pancreatitis. Related to a case].

[Severe ocular symptoms as an initial manifestation of superior vena cava syndrome].

[Diagnosis of the spontaneous subarachnoid hemorrhage with short bleeding or long evolution: report of one case].

[Gastroesophageal reflux as a cause of vocal dysfunction].

Light Source-Dependent Photooxidation of Therapeutic Monoclonal Antibodies: A Comparative Study of Light-Emitting Diode (LED) and Fluorescent Exposure.

Single-cell immune profiling of blood and thrombus in cancer-associated thrombosis.

BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.

Myeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.

Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

Non-coding RNAs as predictive factors of oncological outcomes in plasma cell myeloma.

Related Experiment Videos

[Liver disease patients with anti-HCV. What can be done?]

Related Concept Videos

Related Articles